Prescription drugs

Invicorp is an injectable drug available on prescription. Invicorp 25 micrograms / 2 mg: 1 dose (ampoule 0.35 ml) contains 25 micrograms of aviptadil (vasoactive intestinal polypeptide) and 2 mg of phentolamine mesilate. Invicorp is available in packs of 2 and 5 ampoules. Therapeutic indications: symptomatic treatment of erectile dysfunction with neurogenic, vascular, psychogenic or mixed etiology in adult men. Contraindications: Men for whom sexual activity is not suitable or is contraindicated due to organic disease. Treatment with anticoagulants such as heparin and warfarin, including oral anticoagulants, such as dabigartan, rivaroxaban or apixaban. Men with any of the following conditions should not be treated with Invicorp: conditions that can predispose to priapism such as sickle cell anemia, multiple myeloma or leukemia. Hypersensitivity to the active substances or to any of the excipients.
Side effects: common side effects are flushing and bruising. Uncommon side effects include dizziness, headache, palpitations, tachycardia and hematoma. Rare side effects are priapism, penile nodules / fibrosis (after multiple injections) and pain after injection. Very rare side effects are myocardial infarction and angina pectoris. For further information, see the Summary of Product Characteristics or www.fass.se.
Evolan Pharma AB, tel. 08 - 544 960 30

Invicorp should be administered by direct intracavernous injection. The first injections of Invicorp must be given by healthcare professionals and after proper training, Invicorp can be injected into the home. Patients should be monitored regularly (eg, every three months), especially during the initial period of self-injection.
www.fass.se/Invicorp

Indications: Melatan contains the active substance melatonin and is intended for short-term treatment of jet lag in adults over 18 years. The drug is recommended for adults over the age of 18 who fly over at least 5 time zones, especially to the east, and especially if they have experienced jet lag symptoms during previous trips. If needed, it can also be used by travelers passing 2–4 time zones.
Warnings: The timing of the intake of melatonin is important. Melatan should be used as directions describes. Melatonin can cause drowsiness. The drug should therefore be used with caution if the effects of drowsiness are likely to pose safety risks.
There are no clinical data on the use of melatonin in people with autoimmune disorders. Therefore, Melatan is not recommended for patients with autoimmune disorders.
Hepatic and renal impairment:
There is only limited experience/data regarding the safety and efficacy of melatonin use in patients with hepatic or renal impairment. Melatan is not recommended for patients with hepatic impairment or severe renal impairment.
Read the package leaflet carefully before use. Always take this medicine as your doctor prescribes or the pharmacist has told you. Ask your doctor or pharmacist if you are unsure.
Drug benefit and price: Melatan is not included in the benefit system. For current prices, see Fass.se. Product Summary updated 2019-09-06. For more information visit www.fass.se
Evolan Pharma AB, Box 120, SE-182 12 Danderyd, Sweden. www.evolan.se